Motif ID: Chd1_Pml
Z-value: 4.114
Transcription factors associated with Chd1_Pml:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Chd1 | ENSMUSG00000023852.7 | Chd1 |
| Pml | ENSMUSG00000036986.10 | Pml |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Pml | mm10_v2_chr9_-_58249660_58249672 | -0.56 | 1.6e-07 | Click! |
| Chd1 | mm10_v2_chr17_+_15704963_15704994 | 0.34 | 2.2e-03 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 23.6 | 70.8 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 19.8 | 59.4 | GO:0060596 | mammary placode formation(GO:0060596) |
| 18.5 | 111.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 17.0 | 51.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 13.3 | 53.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
| 13.2 | 52.9 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 11.7 | 46.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 11.6 | 34.7 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 11.4 | 34.1 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
| 11.3 | 33.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
| 10.4 | 31.2 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 9.9 | 49.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 9.3 | 9.3 | GO:2000830 | vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 9.0 | 18.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 8.8 | 26.5 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 8.4 | 41.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 8.1 | 24.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 8.0 | 32.0 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 7.5 | 37.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 7.2 | 21.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 7.2 | 21.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 7.1 | 21.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 6.9 | 20.6 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
| 6.8 | 34.1 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 6.8 | 34.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 6.6 | 19.9 | GO:1900133 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 6.6 | 19.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 6.5 | 6.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 6.1 | 24.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 6.1 | 6.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 6.0 | 36.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 6.0 | 35.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 6.0 | 11.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 6.0 | 35.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 5.9 | 95.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 5.9 | 35.3 | GO:0009405 | pathogenesis(GO:0009405) |
| 5.9 | 35.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 5.9 | 5.9 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 5.9 | 23.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 5.8 | 17.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 5.7 | 28.7 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 5.7 | 34.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 5.6 | 28.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 5.6 | 67.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 5.5 | 55.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 5.5 | 27.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 5.4 | 16.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 5.4 | 16.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 5.3 | 69.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 5.3 | 5.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 5.3 | 10.6 | GO:0061744 | motor behavior(GO:0061744) |
| 5.2 | 25.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 5.1 | 15.4 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 5.1 | 25.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 5.1 | 86.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 5.0 | 15.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 5.0 | 15.0 | GO:0002842 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 5.0 | 14.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 4.9 | 19.7 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 4.9 | 24.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 4.9 | 58.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
| 4.9 | 19.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 4.8 | 19.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 4.8 | 24.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 4.8 | 14.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 4.6 | 13.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 4.5 | 13.6 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 4.5 | 22.6 | GO:0051012 | microtubule sliding(GO:0051012) |
| 4.5 | 18.0 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 4.5 | 13.5 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 4.4 | 26.4 | GO:0032439 | endosome localization(GO:0032439) |
| 4.4 | 13.2 | GO:0007525 | somatic muscle development(GO:0007525) |
| 4.4 | 8.8 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 4.4 | 39.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 4.3 | 21.7 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 4.2 | 38.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 4.2 | 17.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 4.2 | 12.6 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 4.2 | 12.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 4.2 | 12.5 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 4.1 | 16.6 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 4.1 | 62.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 4.1 | 12.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 4.1 | 45.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 4.0 | 12.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 4.0 | 12.1 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 4.0 | 20.1 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 4.0 | 24.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 4.0 | 12.0 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 4.0 | 23.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 4.0 | 39.6 | GO:0046959 | habituation(GO:0046959) |
| 4.0 | 15.8 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 3.9 | 19.7 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 3.9 | 11.8 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 3.9 | 23.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 3.9 | 19.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 3.9 | 23.4 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 3.8 | 46.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 3.8 | 7.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 3.8 | 3.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 3.8 | 42.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 3.8 | 11.4 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 3.8 | 22.6 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 3.7 | 29.7 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 3.7 | 11.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 3.7 | 7.4 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 3.7 | 22.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 3.7 | 11.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 3.7 | 22.0 | GO:0051665 | membrane raft localization(GO:0051665) |
| 3.7 | 11.0 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 3.6 | 25.5 | GO:0051775 | response to redox state(GO:0051775) |
| 3.6 | 3.6 | GO:0042756 | drinking behavior(GO:0042756) |
| 3.6 | 10.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 3.5 | 17.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 3.5 | 3.5 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 3.4 | 24.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 3.4 | 13.7 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 3.4 | 6.8 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 3.4 | 3.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 3.3 | 16.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 3.3 | 60.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 3.3 | 23.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 3.3 | 26.4 | GO:0097264 | self proteolysis(GO:0097264) |
| 3.2 | 13.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 3.2 | 42.1 | GO:0070842 | aggresome assembly(GO:0070842) |
| 3.2 | 22.6 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 3.2 | 32.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 3.2 | 9.5 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 3.2 | 12.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 3.1 | 9.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 3.1 | 6.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 3.1 | 6.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 3.1 | 6.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 3.1 | 3.1 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 3.1 | 27.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 3.1 | 9.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 3.0 | 21.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 3.0 | 9.1 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) |
| 3.0 | 12.0 | GO:2000834 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) regulation of testosterone secretion(GO:2000843) |
| 3.0 | 12.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 3.0 | 3.0 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
| 2.9 | 17.6 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 2.9 | 41.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 2.9 | 8.8 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 2.9 | 14.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 2.9 | 34.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 2.9 | 20.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.9 | 2.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 2.9 | 8.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 2.9 | 8.6 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 2.9 | 17.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 2.8 | 14.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 2.8 | 19.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 2.8 | 11.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 2.8 | 16.8 | GO:0016266 | O-glycan processing(GO:0016266) |
| 2.8 | 14.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 2.8 | 19.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 2.8 | 11.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 2.8 | 19.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 2.8 | 13.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 2.7 | 13.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 2.7 | 27.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 2.7 | 2.7 | GO:0071380 | cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 2.7 | 19.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 2.7 | 2.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 2.7 | 19.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 2.7 | 10.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 2.7 | 5.4 | GO:1902336 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 2.7 | 21.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 2.7 | 8.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.7 | 10.7 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 2.7 | 8.0 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 2.6 | 5.2 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 2.6 | 15.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.6 | 13.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 2.6 | 2.6 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 2.6 | 46.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 2.6 | 26.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 2.6 | 2.6 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 2.6 | 44.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 2.6 | 18.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 2.6 | 20.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 2.6 | 10.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 2.6 | 15.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 2.6 | 12.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 2.5 | 5.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 2.5 | 10.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 2.5 | 10.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 2.5 | 7.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 2.5 | 7.5 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 2.5 | 10.0 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 2.5 | 15.0 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 2.5 | 5.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 2.5 | 2.5 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 2.4 | 7.3 | GO:1901355 | response to rapamycin(GO:1901355) |
| 2.4 | 19.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 2.4 | 29.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 2.4 | 7.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 2.4 | 12.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 2.4 | 4.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 2.4 | 7.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 2.4 | 16.6 | GO:0030242 | pexophagy(GO:0030242) |
| 2.4 | 4.7 | GO:0021586 | pons maturation(GO:0021586) |
| 2.4 | 4.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 2.4 | 7.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 2.4 | 4.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 2.4 | 7.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 2.4 | 11.8 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 2.3 | 7.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 2.3 | 13.9 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 2.3 | 20.4 | GO:0060613 | fat pad development(GO:0060613) |
| 2.3 | 11.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 2.3 | 65.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 2.3 | 6.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 2.2 | 2.2 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 2.2 | 8.9 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 2.2 | 31.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 2.2 | 19.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 2.2 | 8.8 | GO:0021764 | amygdala development(GO:0021764) |
| 2.2 | 2.2 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
| 2.2 | 2.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 2.2 | 6.5 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 2.2 | 10.9 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 2.2 | 19.6 | GO:0014850 | response to muscle activity(GO:0014850) |
| 2.2 | 6.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 2.2 | 12.9 | GO:0006477 | protein sulfation(GO:0006477) |
| 2.1 | 12.9 | GO:0019695 | choline metabolic process(GO:0019695) |
| 2.1 | 19.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 2.1 | 2.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 2.1 | 2.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 2.1 | 6.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 2.1 | 2.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 2.1 | 6.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 2.1 | 27.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 2.1 | 10.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 2.1 | 8.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 2.1 | 22.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 2.1 | 2.1 | GO:0035844 | cloaca development(GO:0035844) |
| 2.1 | 37.0 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 2.1 | 2.1 | GO:0060003 | copper ion export(GO:0060003) |
| 2.0 | 6.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 2.0 | 8.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 2.0 | 10.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 2.0 | 2.0 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 2.0 | 6.0 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.0 | 4.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 2.0 | 8.0 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 2.0 | 10.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 2.0 | 2.0 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 2.0 | 8.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 2.0 | 17.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 2.0 | 7.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 2.0 | 25.7 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 2.0 | 5.9 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 2.0 | 2.0 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 2.0 | 5.9 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 2.0 | 11.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 2.0 | 9.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 1.9 | 3.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 1.9 | 5.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 1.9 | 17.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 1.9 | 7.6 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.9 | 1.9 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 1.9 | 1.9 | GO:0090148 | membrane fission(GO:0090148) |
| 1.9 | 1.9 | GO:2000331 | regulation of terminal button organization(GO:2000331) |
| 1.9 | 9.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 1.9 | 3.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 1.9 | 9.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 1.9 | 1.9 | GO:0097324 | melanocyte migration(GO:0097324) |
| 1.8 | 42.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 1.8 | 5.5 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.8 | 31.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 1.8 | 3.7 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 1.8 | 7.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 1.8 | 12.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 1.8 | 16.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.8 | 5.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 1.8 | 7.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 1.8 | 3.6 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
| 1.8 | 5.4 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 1.8 | 17.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.8 | 10.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 1.8 | 1.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 1.7 | 5.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 1.7 | 1.7 | GO:0099563 | modification of synaptic structure(GO:0099563) |
| 1.7 | 25.9 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 1.7 | 10.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 1.7 | 6.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 1.7 | 6.8 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 1.7 | 8.5 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.7 | 5.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
| 1.7 | 18.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 1.7 | 5.0 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.7 | 8.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.7 | 1.7 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 1.7 | 5.0 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.7 | 5.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.7 | 5.0 | GO:0015866 | ADP transport(GO:0015866) |
| 1.7 | 5.0 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 1.6 | 21.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 1.6 | 8.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 1.6 | 3.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.6 | 39.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 1.6 | 19.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.6 | 4.9 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 1.6 | 9.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 1.6 | 8.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 1.6 | 12.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 1.6 | 4.8 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 1.6 | 14.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 1.6 | 7.9 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 1.6 | 15.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 1.6 | 11.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.6 | 25.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 1.5 | 36.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 1.5 | 1.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.5 | 4.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 1.5 | 4.6 | GO:0098885 | actin filament bundle distribution(GO:0070650) modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 1.5 | 3.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 1.5 | 1.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 1.5 | 6.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 1.5 | 4.6 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 1.5 | 48.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 1.5 | 6.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 1.5 | 4.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 1.5 | 4.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 1.5 | 3.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 1.5 | 4.5 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
| 1.5 | 3.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 1.5 | 1.5 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.5 | 8.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 1.5 | 2.9 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
| 1.5 | 4.4 | GO:0010730 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.5 | 1.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 1.5 | 4.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 1.5 | 2.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 1.5 | 4.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 1.5 | 4.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 1.4 | 4.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 1.4 | 1.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 1.4 | 4.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 1.4 | 17.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 1.4 | 7.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 1.4 | 14.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 1.4 | 7.1 | GO:0046689 | response to mercury ion(GO:0046689) |
| 1.4 | 4.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) transepithelial ammonium transport(GO:0070634) |
| 1.4 | 4.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 1.4 | 5.6 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.4 | 9.8 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
| 1.4 | 12.5 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 1.4 | 8.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 1.4 | 1.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 1.3 | 48.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 1.3 | 47.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 1.3 | 1.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 1.3 | 2.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.3 | 2.7 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 1.3 | 9.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 1.3 | 6.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.3 | 5.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.3 | 5.3 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 1.3 | 1.3 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 1.3 | 10.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 1.3 | 2.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 1.3 | 20.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 1.3 | 7.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 1.3 | 3.9 | GO:0009597 | detection of virus(GO:0009597) |
| 1.3 | 1.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.3 | 8.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 1.3 | 3.8 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 1.3 | 2.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 1.3 | 3.8 | GO:0030070 | insulin processing(GO:0030070) |
| 1.3 | 7.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 1.3 | 7.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 1.3 | 1.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
| 1.2 | 2.5 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 1.2 | 3.7 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 1.2 | 3.7 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) |
| 1.2 | 6.2 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.2 | 7.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.2 | 16.9 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 1.2 | 2.4 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
| 1.2 | 3.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 1.2 | 2.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 1.2 | 34.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 1.2 | 13.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 1.2 | 3.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.2 | 8.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 1.2 | 4.8 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.2 | 1.2 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 1.2 | 5.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 1.2 | 2.3 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 1.2 | 5.9 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 1.2 | 4.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 1.2 | 9.3 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 1.2 | 1.2 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
| 1.2 | 2.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 1.2 | 3.5 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
| 1.2 | 12.7 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.2 | 5.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 1.2 | 2.3 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.1 | 5.7 | GO:0099612 | protein localization to axon(GO:0099612) |
| 1.1 | 16.0 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
| 1.1 | 3.4 | GO:1990859 | cellular response to endothelin(GO:1990859) |
| 1.1 | 18.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 1.1 | 9.0 | GO:0006265 | DNA topological change(GO:0006265) |
| 1.1 | 3.4 | GO:0030473 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
| 1.1 | 14.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 1.1 | 3.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 1.1 | 4.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 1.1 | 4.5 | GO:0002188 | translation reinitiation(GO:0002188) |
| 1.1 | 3.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 1.1 | 13.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.1 | 4.4 | GO:0055095 | positive regulation of sequestering of triglyceride(GO:0010890) lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 1.1 | 4.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
| 1.1 | 3.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 1.1 | 4.4 | GO:0072362 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 1.1 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.1 | 7.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 1.1 | 3.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.1 | 3.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 1.1 | 11.9 | GO:0006491 | N-glycan processing(GO:0006491) |
| 1.1 | 8.6 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) |
| 1.1 | 8.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 1.1 | 11.8 | GO:0032418 | lysosome localization(GO:0032418) |
| 1.1 | 3.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 1.1 | 14.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 1.1 | 4.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.1 | 3.2 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 1.1 | 6.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 1.1 | 3.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 1.1 | 5.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 1.1 | 10.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 1.1 | 1.1 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.1 | 12.7 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 1.1 | 7.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 1.1 | 3.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.1 | 4.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.1 | 10.5 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 1.0 | 8.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 1.0 | 14.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 1.0 | 6.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.0 | 2.1 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
| 1.0 | 2.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 1.0 | 4.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 1.0 | 4.1 | GO:0071625 | vocalization behavior(GO:0071625) |
| 1.0 | 7.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 1.0 | 8.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 1.0 | 4.0 | GO:0046541 | saliva secretion(GO:0046541) |
| 1.0 | 11.1 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 1.0 | 2.0 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 1.0 | 1.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 1.0 | 4.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 1.0 | 4.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 1.0 | 3.0 | GO:0060023 | soft palate development(GO:0060023) |
| 1.0 | 7.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.0 | 4.0 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 1.0 | 5.9 | GO:0051647 | nucleus localization(GO:0051647) |
| 1.0 | 3.0 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.0 | 27.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 1.0 | 3.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 1.0 | 3.0 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
| 1.0 | 6.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 1.0 | 11.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 1.0 | 4.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 1.0 | 2.9 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 1.0 | 2.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 1.0 | 21.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 1.0 | 1.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 1.0 | 3.9 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
| 1.0 | 6.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 1.0 | 6.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 1.0 | 3.8 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 1.0 | 3.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 1.0 | 2.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.9 | 3.8 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.9 | 3.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.9 | 22.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.9 | 6.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.9 | 1.9 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.9 | 0.9 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.9 | 4.7 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.9 | 4.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.9 | 11.2 | GO:0060013 | righting reflex(GO:0060013) |
| 0.9 | 28.8 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.9 | 3.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.9 | 5.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.9 | 4.6 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.9 | 3.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.9 | 3.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.9 | 1.8 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
| 0.9 | 3.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.9 | 0.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.9 | 5.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.9 | 5.4 | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.9 | 1.8 | GO:0001757 | somite specification(GO:0001757) |
| 0.9 | 2.7 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.9 | 4.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.9 | 4.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.9 | 2.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.9 | 3.6 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
| 0.9 | 1.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.9 | 3.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.9 | 1.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.9 | 4.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.9 | 25.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.9 | 1.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.9 | 1.8 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.9 | 7.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.9 | 0.9 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.9 | 0.9 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.9 | 6.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.9 | 21.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.9 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.9 | 3.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.9 | 12.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.9 | 12.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.9 | 0.9 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.9 | 0.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.9 | 6.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.9 | 37.8 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.9 | 5.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.9 | 0.9 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
| 0.9 | 2.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.9 | 4.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.8 | 12.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.8 | 3.4 | GO:0006983 | ER overload response(GO:0006983) |
| 0.8 | 6.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.8 | 3.4 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.8 | 5.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.8 | 91.9 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.8 | 6.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.8 | 5.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.8 | 109.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.8 | 5.0 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.8 | 4.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.8 | 7.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.8 | 5.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.8 | 0.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.8 | 7.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.8 | 0.8 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.8 | 13.1 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
| 0.8 | 3.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.8 | 6.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.8 | 4.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.8 | 0.8 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.8 | 5.7 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.8 | 4.0 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.8 | 2.4 | GO:0060437 | lung growth(GO:0060437) |
| 0.8 | 4.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.8 | 4.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.8 | 2.4 | GO:0051168 | nuclear export(GO:0051168) |
| 0.8 | 4.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.8 | 1.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.8 | 1.6 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 0.8 | 5.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.8 | 2.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.8 | 2.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.8 | 2.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.8 | 1.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.8 | 2.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.8 | 51.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.8 | 6.2 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.8 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.8 | 3.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 0.8 | 12.9 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.8 | 1.5 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.8 | 31.9 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.8 | 3.0 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.8 | 2.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.7 | 3.0 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.7 | 6.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.7 | 41.7 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.7 | 2.2 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.7 | 2.2 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.7 | 10.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.7 | 3.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.7 | 5.1 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.7 | 4.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.7 | 1.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.7 | 2.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.7 | 2.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.7 | 2.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.7 | 2.1 | GO:0060379 | cardiac muscle cell myoblast differentiation(GO:0060379) |
| 0.7 | 10.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.7 | 5.7 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.7 | 0.7 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.7 | 0.7 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.7 | 6.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.7 | 0.7 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
| 0.7 | 13.3 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.7 | 21.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.7 | 3.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.7 | 15.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.7 | 2.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.7 | 3.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.7 | 1.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.7 | 4.8 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
| 0.7 | 6.2 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.7 | 1.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.7 | 1.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 | 1.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.7 | 8.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.7 | 6.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.7 | 40.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.7 | 15.6 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.7 | 2.7 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.7 | 6.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.7 | 1.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.7 | 5.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.7 | 4.0 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.7 | 2.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 0.7 | 6.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.7 | 6.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.7 | 13.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.7 | 1.3 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
| 0.7 | 2.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.6 | 5.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.6 | 4.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.6 | 4.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.6 | 5.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.6 | 11.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.6 | 0.6 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.6 | 6.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.6 | 5.1 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.6 | 0.6 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.6 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.6 | 6.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.6 | 2.5 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.6 | 1.8 | GO:1905167 | astrocyte activation involved in immune response(GO:0002265) cellular response to beta-amyloid(GO:1904646) regulation of lysosomal protein catabolic process(GO:1905165) positive regulation of lysosomal protein catabolic process(GO:1905167) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.6 | 2.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.6 | 1.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.6 | 4.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.6 | 6.6 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
| 0.6 | 3.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.6 | 7.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.6 | 4.1 | GO:0001964 | startle response(GO:0001964) |
| 0.6 | 1.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.6 | 0.6 | GO:0060789 | hair follicle placode formation(GO:0060789) |
| 0.6 | 2.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.6 | 1.2 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.6 | 1.8 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.6 | 2.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.6 | 1.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.6 | 2.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.6 | 3.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.6 | 0.6 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.6 | 5.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.6 | 2.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.6 | 0.6 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.6 | 2.8 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.6 | 1.7 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.6 | 1.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.6 | 5.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.5 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.5 | 3.3 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.5 | 3.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.5 | 4.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.5 | 4.9 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.5 | 2.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.5 | 3.2 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.5 | 1.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.5 | 10.7 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.5 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.5 | 1.6 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.5 | 6.9 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 0.5 | 0.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 | 2.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.5 | 2.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 | 2.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.5 | 6.3 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.5 | 1.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.5 | 2.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.5 | 3.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.5 | 3.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.5 | 1.0 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.5 | 10.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.5 | 2.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 | 2.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.5 | 8.1 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.5 | 1.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.5 | 2.5 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 0.5 | 1.5 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.5 | 3.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.5 | 0.5 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
| 0.5 | 3.5 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.5 | 1.0 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.5 | 11.3 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.5 | 2.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.5 | 0.5 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.5 | 2.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.5 | 7.3 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.5 | 2.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.5 | 1.9 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.5 | 4.8 | GO:0048520 | positive regulation of behavior(GO:0048520) |
| 0.5 | 1.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.5 | 1.4 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.5 | 2.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.5 | 5.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.5 | 10.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.5 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.5 | 13.7 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.5 | 2.4 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.5 | 2.8 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
| 0.5 | 4.2 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.5 | 3.3 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.5 | 1.4 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.5 | 0.5 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.5 | 5.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.5 | 23.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.5 | 0.5 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.5 | 5.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.5 | 2.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.5 | 1.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.5 | 1.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.5 | 2.3 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
| 0.4 | 2.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.4 | 1.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.4 | 0.4 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.4 | 1.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 0.4 | 16.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.4 | 1.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.4 | 2.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.4 | 3.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.4 | 4.9 | GO:0006171 | cAMP biosynthetic process(GO:0006171) |
| 0.4 | 2.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.4 | 2.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 | 2.6 | GO:0042026 | protein refolding(GO:0042026) |
| 0.4 | 1.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.4 | 1.3 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.4 | 3.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.4 | 2.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.4 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.4 | 1.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.4 | 10.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.4 | 0.4 | GO:0009202 | purine deoxyribonucleotide biosynthetic process(GO:0009153) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
| 0.4 | 3.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.4 | 2.5 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.4 | 2.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.4 | 1.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.4 | 10.8 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.4 | 5.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.4 | 1.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.4 | 5.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.4 | 1.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 | 2.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.4 | 2.4 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.4 | 8.5 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.4 | 2.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.4 | 3.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.4 | 0.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.4 | 2.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 2.4 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.4 | 2.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.4 | 3.2 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.4 | 2.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.4 | 9.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.4 | 3.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.4 | 0.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.4 | 4.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.4 | 0.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.4 | 2.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.4 | 2.6 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.4 | 1.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.4 | 2.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.4 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.4 | 3.4 | GO:0072666 | establishment of protein localization to vacuole(GO:0072666) |
| 0.4 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.4 | 2.2 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.4 | 1.5 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
| 0.4 | 3.3 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.4 | 1.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.4 | 1.5 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.4 | 0.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.4 | 1.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 | 1.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.4 | 0.4 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.4 | 1.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.4 | 2.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.4 | 1.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.3 | 2.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.3 | 2.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.3 | 1.0 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.3 | 1.0 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.3 | 2.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.3 | 1.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 | 1.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.3 | 0.3 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.3 | 0.7 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
| 0.3 | 1.7 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.3 | 1.7 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.3 | 0.3 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.3 | 10.1 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.3 | 1.3 | GO:0061623 | glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
| 0.3 | 0.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.3 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.3 | 6.0 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.3 | 5.3 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.3 | 2.6 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.3 | 3.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.3 | 1.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 | 3.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.3 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.3 | 1.0 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 | 0.3 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
| 0.3 | 0.6 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.3 | 5.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.3 | 1.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 | 0.6 | GO:0097155 | embryonic heart tube left/right pattern formation(GO:0060971) fasciculation of sensory neuron axon(GO:0097155) |
| 0.3 | 3.7 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.3 | 1.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.3 | 0.3 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.3 | 0.9 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.3 | 1.2 | GO:0070474 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.3 | 1.5 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.3 | 2.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.3 | 0.9 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) negative regulation of sequestering of triglyceride(GO:0010891) sequestering of triglyceride(GO:0030730) |
| 0.3 | 0.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 0.3 | 0.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.3 | 1.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.3 | 1.2 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
| 0.3 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.3 | 2.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.3 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.3 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.3 | 0.8 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.3 | 1.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.3 | 3.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 | 1.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.3 | 3.6 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.3 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 | 0.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.3 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.3 | 0.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 1.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 | 0.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.3 | 0.8 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.3 | 2.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.3 | 0.5 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.3 | 1.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.3 | 2.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.3 | 2.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 0.7 | GO:0050716 | regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 | 0.5 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.2 | 1.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.2 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.2 | 0.5 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 | 2.4 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.2 | 1.7 | GO:0009301 | snRNA transcription(GO:0009301) |
| 0.2 | 0.5 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.2 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 1.9 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.2 | 3.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.2 | 1.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 5.5 | GO:0090307 | mitotic spindle assembly(GO:0090307) |
| 0.2 | 1.9 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.2 | 7.3 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.2 | 1.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.2 | 2.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 3.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.2 | 0.5 | GO:0015867 | ATP transport(GO:0015867) |
| 0.2 | 1.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.2 | 2.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.2 | 2.0 | GO:0036093 | germ cell proliferation(GO:0036093) |
| 0.2 | 0.2 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.2 | 1.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.2 | 1.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.2 | 0.6 | GO:1904152 | regulation of protein exit from endoplasmic reticulum(GO:0070861) negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) negative regulation of ERAD pathway(GO:1904293) |
| 0.2 | 1.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 1.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 | 3.5 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.2 | 0.8 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.2 | 5.1 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.2 | 0.8 | GO:0043144 | snoRNA 3'-end processing(GO:0031126) snoRNA processing(GO:0043144) |
| 0.2 | 5.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 1.6 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.2 | 0.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.2 | 1.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 | 1.0 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.2 | 3.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 | 0.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.2 | 3.6 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.2 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.2 | 0.6 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.2 | 1.9 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
| 0.2 | 0.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.2 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 1.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 0.7 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 0.3 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.2 | 1.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 | 2.1 | GO:0033622 | integrin activation(GO:0033622) |
| 0.2 | 4.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.2 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.2 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
| 0.2 | 0.2 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
| 0.2 | 1.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.2 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.2 | 2.3 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.2 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.2 | 1.1 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
| 0.2 | 2.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.2 | 2.0 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.5 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.2 | 1.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 | 0.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.2 | 0.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 | 0.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 6.0 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 2.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.1 | 0.7 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 | 3.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
| 0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 1.5 | GO:0036065 | fucosylation(GO:0036065) |
| 0.1 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.1 | 4.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.1 | 0.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.1 | 0.4 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 0.8 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) |
| 0.1 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
| 0.1 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 3.9 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 1.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 1.2 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.6 | GO:0042148 | strand invasion(GO:0042148) |
| 0.1 | 3.0 | GO:0043631 | RNA polyadenylation(GO:0043631) |
| 0.1 | 1.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.1 | 0.4 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
| 0.1 | 0.5 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.1 | 1.7 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.1 | 0.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 2.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.1 | 1.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 2.5 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 1.5 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 0.2 | GO:0046967 | protection from natural killer cell mediated cytotoxicity(GO:0042270) cytosol to ER transport(GO:0046967) |
| 0.1 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.4 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.1 | 1.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 1.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 1.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.7 | GO:0030317 | sperm motility(GO:0030317) |
| 0.1 | 0.4 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 | 0.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 | 0.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 | 0.6 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.1 | 0.5 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 7.5 | GO:0006457 | protein folding(GO:0006457) |
| 0.1 | 0.3 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 0.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 2.8 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.1 | 0.8 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.1 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 5.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.4 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
| 0.1 | 2.0 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.1 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 | 0.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 | 0.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.1 | 2.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.1 | 2.9 | GO:0090174 | organelle membrane fusion(GO:0090174) |
| 0.1 | 1.6 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.1 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.1 | 0.3 | GO:0046103 | inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
| 0.0 | 0.1 | GO:0010543 | regulation of platelet activation(GO:0010543) |
| 0.0 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.0 | 0.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 | 0.1 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.0 | 0.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.8 | GO:0007051 | spindle organization(GO:0007051) |
| 0.0 | 0.8 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 | 0.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.0 | 0.4 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
| 0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 | 0.1 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.0 | 0.2 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 | 0.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.0 | 0.1 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 | 0.1 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 1.4 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
| 0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 | 0.0 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 | 0.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 17.7 | 53.0 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
| 17.5 | 104.9 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 10.9 | 65.4 | GO:0005955 | calcineurin complex(GO:0005955) |
| 9.9 | 29.8 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
| 9.6 | 57.5 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 8.1 | 8.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 7.3 | 22.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 7.2 | 35.9 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 6.7 | 20.0 | GO:0005940 | septin ring(GO:0005940) |
| 6.6 | 19.8 | GO:0018444 | translation release factor complex(GO:0018444) |
| 5.6 | 16.9 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 5.3 | 21.2 | GO:0044307 | dendritic branch(GO:0044307) |
| 5.0 | 15.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 5.0 | 30.1 | GO:0008091 | spectrin(GO:0008091) |
| 5.0 | 34.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 4.8 | 28.6 | GO:0045179 | apical cortex(GO:0045179) |
| 4.7 | 14.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 4.7 | 14.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 4.4 | 53.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 4.4 | 13.2 | GO:0098855 | HCN channel complex(GO:0098855) |
| 4.4 | 44.1 | GO:0045298 | tubulin complex(GO:0045298) |
| 4.3 | 26.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 4.3 | 55.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 4.1 | 41.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 4.1 | 12.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 4.0 | 12.1 | GO:0072534 | perineuronal net(GO:0072534) |
| 4.0 | 51.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 4.0 | 4.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 4.0 | 7.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 3.9 | 11.7 | GO:0048179 | activin receptor complex(GO:0048179) |
| 3.8 | 34.1 | GO:0005883 | neurofilament(GO:0005883) |
| 3.8 | 56.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 3.7 | 18.4 | GO:0000235 | astral microtubule(GO:0000235) |
| 3.7 | 3.7 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
| 3.7 | 18.3 | GO:1902710 | GABA receptor complex(GO:1902710) |
| 3.5 | 13.8 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 3.4 | 13.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 3.4 | 10.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 3.2 | 22.6 | GO:0070695 | FHF complex(GO:0070695) |
| 3.2 | 135.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 3.2 | 32.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 3.2 | 140.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 3.2 | 16.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 3.1 | 56.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 3.0 | 118.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 3.0 | 12.2 | GO:0032280 | symmetric synapse(GO:0032280) |
| 2.9 | 23.5 | GO:0042382 | paraspeckles(GO:0042382) |
| 2.9 | 14.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 2.9 | 5.8 | GO:0005642 | annulate lamellae(GO:0005642) |
| 2.8 | 8.4 | GO:0044194 | cytolytic granule(GO:0044194) |
| 2.8 | 19.3 | GO:0005827 | polar microtubule(GO:0005827) |
| 2.8 | 8.3 | GO:0044308 | axonal spine(GO:0044308) |
| 2.7 | 49.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 2.7 | 8.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 2.6 | 5.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 2.6 | 13.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 2.6 | 10.3 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
| 2.5 | 15.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 2.5 | 37.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 2.5 | 19.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 2.5 | 22.3 | GO:0070852 | cell body fiber(GO:0070852) |
| 2.4 | 2.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 2.4 | 7.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 2.4 | 4.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 2.3 | 11.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 2.3 | 2.3 | GO:0000346 | transcription export complex(GO:0000346) |
| 2.3 | 6.8 | GO:0031251 | PAN complex(GO:0031251) |
| 2.3 | 4.5 | GO:0001739 | sex chromatin(GO:0001739) |
| 2.2 | 6.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 2.2 | 63.7 | GO:0033268 | node of Ranvier(GO:0033268) |
| 2.2 | 6.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 2.2 | 49.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 2.2 | 21.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 2.1 | 12.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 2.1 | 6.3 | GO:0097433 | dense body(GO:0097433) |
| 2.1 | 6.2 | GO:0031417 | NatC complex(GO:0031417) |
| 2.1 | 6.2 | GO:0043293 | apoptosome(GO:0043293) |
| 2.1 | 64.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 2.1 | 4.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 2.0 | 54.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 2.0 | 10.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 2.0 | 4.0 | GO:0016342 | catenin complex(GO:0016342) |
| 2.0 | 2.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 2.0 | 19.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 1.9 | 3.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 1.9 | 1.9 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 1.9 | 46.6 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 1.9 | 3.7 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 1.9 | 133.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 1.8 | 119.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 1.8 | 23.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.8 | 42.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 1.8 | 3.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 1.8 | 1.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 1.7 | 5.2 | GO:0034657 | GID complex(GO:0034657) |
| 1.7 | 81.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 1.7 | 8.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 1.7 | 382.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 1.7 | 8.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.6 | 3.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 1.6 | 6.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 1.6 | 14.5 | GO:0016363 | nuclear matrix(GO:0016363) |
| 1.5 | 13.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 1.5 | 9.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 1.5 | 3.0 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.5 | 10.4 | GO:0030673 | axolemma(GO:0030673) |
| 1.5 | 1.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 1.5 | 14.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 1.5 | 20.5 | GO:0016589 | NURF complex(GO:0016589) |
| 1.4 | 36.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 1.4 | 2.9 | GO:0043512 | inhibin A complex(GO:0043512) |
| 1.4 | 5.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 1.4 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.4 | 1.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 1.4 | 17.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 1.4 | 2.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 1.4 | 4.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 1.4 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
| 1.4 | 1.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 1.4 | 1.4 | GO:0030689 | Noc complex(GO:0030689) |
| 1.4 | 16.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 1.4 | 1.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 1.3 | 18.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.3 | 35.6 | GO:0002102 | podosome(GO:0002102) |
| 1.3 | 6.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 1.3 | 7.8 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 1.3 | 6.5 | GO:0072487 | MSL complex(GO:0072487) |
| 1.3 | 15.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 1.3 | 60.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 1.3 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 1.3 | 17.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 1.2 | 13.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 1.2 | 9.8 | GO:0032590 | dendrite membrane(GO:0032590) |
| 1.2 | 23.2 | GO:0000145 | exocyst(GO:0000145) |
| 1.2 | 1.2 | GO:0002141 | stereocilia ankle link(GO:0002141) |
| 1.2 | 17.0 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 1.2 | 45.0 | GO:0032420 | stereocilium(GO:0032420) |
| 1.2 | 2.3 | GO:0042585 | germinal vesicle(GO:0042585) |
| 1.2 | 212.7 | GO:0099572 | postsynaptic specialization(GO:0099572) |
| 1.2 | 23.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 1.2 | 4.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 1.1 | 19.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 1.1 | 5.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 1.1 | 7.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 1.1 | 69.7 | GO:0043195 | terminal bouton(GO:0043195) |
| 1.1 | 10.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 1.1 | 6.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 1.1 | 32.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 1.1 | 21.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 1.1 | 2.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 1.1 | 46.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 1.0 | 12.6 | GO:0014704 | intercalated disc(GO:0014704) |
| 1.0 | 7.3 | GO:0071203 | WASH complex(GO:0071203) |
| 1.0 | 2.1 | GO:0071920 | cleavage body(GO:0071920) |
| 1.0 | 12.5 | GO:0046930 | pore complex(GO:0046930) |
| 1.0 | 16.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 1.0 | 5.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.0 | 16.7 | GO:0034704 | calcium channel complex(GO:0034704) |
| 1.0 | 2.9 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.9 | 8.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.9 | 23.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.9 | 11.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.9 | 9.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.9 | 4.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.9 | 1.7 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.8 | 2.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.8 | 5.1 | GO:0000938 | GARP complex(GO:0000938) |
| 0.8 | 8.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.8 | 5.9 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.8 | 2.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.8 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.8 | 5.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.8 | 8.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.8 | 1.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.8 | 4.0 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.8 | 2.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.8 | 3.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.8 | 42.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.8 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.8 | 51.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.8 | 2.3 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.8 | 12.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.8 | 29.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.8 | 2.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.7 | 23.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.7 | 1.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.7 | 2.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.7 | 3.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.7 | 2.8 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.7 | 20.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.7 | 34.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.7 | 3.5 | GO:0001652 | granular component(GO:0001652) |
| 0.7 | 1.4 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.7 | 5.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.7 | 3.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.7 | 5.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.7 | 12.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.7 | 3.4 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.7 | 2.0 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.7 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.7 | 6.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.7 | 4.0 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.7 | 22.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.7 | 4.6 | GO:0089701 | U2AF(GO:0089701) |
| 0.6 | 2.6 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.6 | 10.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.6 | 11.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.6 | 3.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.6 | 11.8 | GO:0005902 | microvillus(GO:0005902) |
| 0.6 | 2.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.6 | 5.6 | GO:0043196 | varicosity(GO:0043196) |
| 0.6 | 12.4 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
| 0.6 | 21.4 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.6 | 20.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.6 | 1.8 | GO:1990357 | terminal web(GO:1990357) |
| 0.6 | 1.8 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
| 0.6 | 15.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.6 | 4.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.6 | 5.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.6 | 11.3 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.6 | 7.9 | GO:0043034 | costamere(GO:0043034) |
| 0.6 | 12.3 | GO:1990752 | microtubule end(GO:1990752) |
| 0.6 | 2.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.6 | 10.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.6 | 13.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.5 | 6.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.5 | 2.7 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.5 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.5 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.5 | 1.6 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.5 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.5 | 1.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.5 | 1.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.5 | 5.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.5 | 16.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.5 | 6.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.5 | 7.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.5 | 1.5 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
| 0.5 | 36.3 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.5 | 4.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.5 | 8.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.5 | 2.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.5 | 2.4 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.5 | 12.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.5 | 2.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.5 | 4.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.5 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.5 | 1.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.5 | 1.9 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.5 | 14.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.5 | 34.5 | GO:0005903 | brush border(GO:0005903) |
| 0.4 | 4.9 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.4 | 0.9 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.4 | 2.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.4 | 5.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.4 | 6.4 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.4 | 39.4 | GO:0005769 | early endosome(GO:0005769) |
| 0.4 | 0.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.4 | 0.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 2.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.4 | 8.5 | GO:0005921 | gap junction(GO:0005921) |
| 0.4 | 99.0 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.4 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.4 | 6.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.4 | 1.6 | GO:0044304 | main axon(GO:0044304) |
| 0.4 | 4.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.4 | 4.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.4 | 2.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.4 | 5.4 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.4 | 11.9 | GO:0005814 | centriole(GO:0005814) |
| 0.4 | 3.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.4 | 2.3 | GO:0045120 | pronucleus(GO:0045120) |
| 0.4 | 1.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.4 | 23.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.4 | 1.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.4 | 38.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.4 | 3.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.3 | 3.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.3 | 1.0 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.3 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.3 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.3 | 7.3 | GO:0001741 | XY body(GO:0001741) |
| 0.3 | 2.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.3 | 1.0 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.3 | 15.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.3 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.3 | 2.5 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.3 | 1.6 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.3 | 1.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.3 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.3 | 4.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.3 | 0.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.3 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 1.5 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.3 | 13.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.3 | 2.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.3 | 16.5 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.3 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.3 | 1.4 | GO:0030914 | STAGA complex(GO:0030914) SAGA-type complex(GO:0070461) |
| 0.3 | 4.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 2.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.3 | 1.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.3 | 3.9 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.3 | 0.8 | GO:0090543 | Flemming body(GO:0090543) |
| 0.3 | 2.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.3 | 10.7 | GO:0043204 | perikaryon(GO:0043204) |
| 0.3 | 4.7 | GO:0016605 | PML body(GO:0016605) |
| 0.3 | 3.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.3 | 0.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.3 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 38.4 | GO:0044297 | cell body(GO:0044297) |
| 0.3 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.3 | 1.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 2.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.3 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 4.1 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.3 | 1.5 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.3 | 4.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.3 | 6.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.2 | 12.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 0.7 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.2 | 8.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.2 | 1.2 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.2 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 51.5 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.2 | 1.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.2 | 3.9 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 41.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.2 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.2 | 2.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.2 | 2.2 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.2 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 4.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 19.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.2 | 6.5 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.2 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
| 0.2 | 14.8 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.2 | 2.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.2 | 1.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.2 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 0.6 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.2 | 9.6 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.2 | 17.5 | GO:0005929 | cilium(GO:0005929) |
| 0.2 | 2.9 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.2 | 1.1 | GO:0098858 | filopodium(GO:0030175) actin-based cell projection(GO:0098858) |
| 0.2 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.2 | 2.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.2 | 14.8 | GO:0005768 | endosome(GO:0005768) |
| 0.2 | 4.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.2 | 2.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 2.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 2.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 3.7 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.2 | 6.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.2 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
| 0.2 | 1.1 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 0.3 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 0.7 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.1 | 4.4 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 0.8 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 122.7 | GO:0005886 | plasma membrane(GO:0005886) |
| 0.1 | 2.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 8.6 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 361.4 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.1 | 3.4 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 1.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 0.4 | GO:1990351 | transporter complex(GO:1990351) |
| 0.1 | 1.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.1 | 2.2 | GO:0005657 | replication fork(GO:0005657) |
| 0.1 | 1.9 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
| 0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 4.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.1 | 6.6 | GO:0097708 | intracellular vesicle(GO:0097708) |
| 0.1 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.6 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.0 | 2.7 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.0 | 1.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.0 | 0.4 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 4.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 5.0 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
| 0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.0 | 0.0 | GO:0045171 | intercellular bridge(GO:0045171) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 17.8 | 53.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 10.8 | 43.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 10.0 | 59.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 9.8 | 29.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 8.9 | 62.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
| 8.7 | 26.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 8.5 | 42.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 7.6 | 45.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 7.5 | 22.5 | GO:0051379 | epinephrine binding(GO:0051379) |
| 7.2 | 36.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 6.9 | 20.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 6.8 | 20.5 | GO:0031208 | POZ domain binding(GO:0031208) |
| 6.8 | 27.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 6.6 | 19.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 6.6 | 26.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 6.5 | 71.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 6.3 | 31.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 6.2 | 43.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 6.2 | 43.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 6.1 | 6.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 6.1 | 6.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 5.9 | 23.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 5.9 | 35.4 | GO:0002135 | CTP binding(GO:0002135) |
| 5.9 | 17.7 | GO:0019002 | GMP binding(GO:0019002) |
| 5.8 | 23.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 5.8 | 34.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 5.7 | 40.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 5.4 | 16.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 5.2 | 25.9 | GO:0004359 | glutaminase activity(GO:0004359) |
| 5.0 | 30.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 4.8 | 4.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 4.7 | 18.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 4.7 | 9.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 4.6 | 74.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 4.6 | 13.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 4.6 | 59.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 4.5 | 44.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 4.4 | 17.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 4.4 | 13.1 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 4.3 | 21.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 4.2 | 70.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 4.1 | 12.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 4.1 | 12.4 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 4.1 | 28.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 4.1 | 16.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 4.1 | 36.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 4.1 | 32.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 4.0 | 20.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 4.0 | 16.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 4.0 | 15.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 4.0 | 71.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 3.9 | 23.4 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 3.9 | 19.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 3.8 | 61.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 3.8 | 26.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 3.6 | 10.7 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 3.6 | 14.2 | GO:0034046 | poly(G) binding(GO:0034046) |
| 3.5 | 10.6 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 3.5 | 21.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 3.5 | 31.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 3.5 | 24.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 3.4 | 13.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 3.3 | 13.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 3.3 | 13.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 3.3 | 19.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 3.3 | 13.2 | GO:0036033 | mediator complex binding(GO:0036033) |
| 3.3 | 19.5 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 3.2 | 12.9 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 3.2 | 19.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 3.2 | 19.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 3.1 | 52.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 3.0 | 12.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 3.0 | 21.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 2.9 | 46.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 2.9 | 55.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 2.9 | 2.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 2.9 | 8.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 2.8 | 8.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 2.8 | 11.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 2.7 | 8.2 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
| 2.7 | 10.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 2.7 | 21.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 2.7 | 21.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 2.7 | 8.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 2.6 | 15.8 | GO:0043559 | insulin binding(GO:0043559) |
| 2.6 | 7.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 2.6 | 15.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 2.6 | 25.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 2.6 | 7.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 2.6 | 38.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 2.5 | 15.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 2.5 | 24.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 2.5 | 14.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 2.5 | 2.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 2.5 | 17.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 2.4 | 19.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 2.4 | 9.8 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 2.4 | 41.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 2.4 | 12.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 2.4 | 14.5 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 2.4 | 9.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 2.4 | 45.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 2.4 | 7.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 2.4 | 11.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 2.4 | 40.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 2.3 | 98.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 2.3 | 7.0 | GO:0045340 | mercury ion binding(GO:0045340) |
| 2.3 | 62.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 2.3 | 16.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 2.3 | 13.7 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
| 2.2 | 18.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 2.2 | 13.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 2.2 | 6.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 2.2 | 24.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 2.2 | 11.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 2.2 | 4.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 2.2 | 2.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 2.2 | 6.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 2.2 | 10.9 | GO:0097001 | ceramide binding(GO:0097001) |
| 2.2 | 13.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 2.1 | 12.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 2.1 | 40.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 2.1 | 12.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 2.1 | 2.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 2.1 | 8.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 2.1 | 2.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 2.1 | 10.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 2.1 | 10.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
| 2.1 | 2.1 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 2.1 | 6.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 2.0 | 10.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 2.0 | 89.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 2.0 | 23.8 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 2.0 | 11.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 2.0 | 5.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 2.0 | 25.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 2.0 | 33.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 1.9 | 19.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 1.9 | 40.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 1.9 | 40.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 1.9 | 17.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 1.9 | 19.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 1.9 | 82.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 1.9 | 11.3 | GO:0035197 | siRNA binding(GO:0035197) |
| 1.9 | 1.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 1.9 | 5.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 1.9 | 20.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.9 | 26.0 | GO:0031005 | filamin binding(GO:0031005) |
| 1.9 | 27.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 1.8 | 5.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 1.8 | 10.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 1.8 | 25.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 1.8 | 1.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 1.8 | 8.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.8 | 53.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 1.8 | 7.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 1.8 | 53.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 1.8 | 24.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 1.7 | 8.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 1.7 | 10.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.7 | 5.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 1.7 | 8.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 1.7 | 3.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 1.7 | 5.0 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 1.6 | 4.9 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 1.6 | 19.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 1.6 | 4.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.6 | 12.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.6 | 4.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 1.5 | 4.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 1.5 | 26.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 1.5 | 7.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 1.5 | 7.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 1.5 | 7.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 1.5 | 6.0 | GO:0019808 | polyamine binding(GO:0019808) |
| 1.5 | 9.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 1.5 | 13.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.5 | 13.3 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 1.5 | 4.4 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 1.5 | 13.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 1.5 | 5.9 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
| 1.5 | 4.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 1.5 | 5.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 1.5 | 150.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 1.5 | 4.4 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
| 1.4 | 1.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.4 | 1.4 | GO:0032142 | single guanine insertion binding(GO:0032142) |
| 1.4 | 22.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 1.4 | 4.3 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 1.4 | 7.1 | GO:0019894 | kinesin binding(GO:0019894) |
| 1.4 | 4.2 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.4 | 2.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 1.4 | 8.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 1.4 | 4.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.4 | 8.3 | GO:0043426 | MRF binding(GO:0043426) |
| 1.4 | 55.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 1.4 | 4.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 1.4 | 4.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 1.4 | 32.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 1.3 | 5.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 1.3 | 10.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 1.3 | 16.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 1.3 | 6.7 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 1.3 | 6.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.3 | 8.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 1.3 | 9.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 1.3 | 10.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 1.3 | 15.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 1.3 | 6.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 1.3 | 3.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 1.3 | 33.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 1.3 | 11.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 1.3 | 1.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 1.3 | 14.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 1.3 | 36.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 1.3 | 6.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 1.2 | 6.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 1.2 | 3.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 1.2 | 9.8 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 1.2 | 43.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 1.2 | 15.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 1.2 | 15.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 1.2 | 5.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 1.1 | 4.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 1.1 | 11.2 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 1.1 | 27.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 1.1 | 5.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.1 | 12.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 1.1 | 7.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 1.1 | 22.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 1.1 | 20.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 1.1 | 31.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 1.1 | 4.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 1.1 | 4.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 1.0 | 7.3 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 1.0 | 6.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 1.0 | 6.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.0 | 7.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 1.0 | 1.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) MutSalpha complex binding(GO:0032407) |
| 1.0 | 3.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 1.0 | 28.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 1.0 | 22.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 1.0 | 2.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 1.0 | 6.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 1.0 | 46.9 | GO:0030507 | spectrin binding(GO:0030507) |
| 1.0 | 2.9 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.0 | 21.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 1.0 | 4.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 1.0 | 4.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 1.0 | 3.8 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
| 1.0 | 1.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 1.0 | 3.8 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 1.0 | 59.1 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.9 | 4.7 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.9 | 7.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.9 | 62.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.9 | 2.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.9 | 12.2 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.9 | 24.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.9 | 2.8 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.9 | 8.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.9 | 33.1 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.9 | 2.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.9 | 15.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.9 | 12.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.9 | 5.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.9 | 1.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.9 | 11.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.9 | 5.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.9 | 6.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.9 | 8.6 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.9 | 2.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.8 | 32.8 | GO:0045502 | dynein binding(GO:0045502) |
| 0.8 | 2.5 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
| 0.8 | 0.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.8 | 6.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.8 | 6.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.8 | 16.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.8 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.8 | 1.6 | GO:2001070 | starch binding(GO:2001070) |
| 0.8 | 14.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.8 | 4.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 0.8 | 3.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.8 | 39.8 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.8 | 8.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.8 | 3.2 | GO:0004692 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cGMP-dependent protein kinase activity(GO:0004692) |
| 0.8 | 2.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.8 | 3.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.8 | 3.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.7 | 12.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.7 | 4.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.7 | 4.5 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.7 | 68.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.7 | 13.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.7 | 5.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.7 | 1.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.7 | 2.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.7 | 6.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.7 | 2.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.7 | 7.9 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.7 | 2.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.7 | 5.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.7 | 5.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.7 | 0.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.7 | 4.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.7 | 1.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.7 | 2.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.7 | 3.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.7 | 3.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.7 | 3.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.7 | 8.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.7 | 2.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.7 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.7 | 35.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.7 | 19.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.7 | 2.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.7 | 6.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.7 | 2.7 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.7 | 9.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.7 | 34.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.7 | 8.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.7 | 3.9 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.7 | 28.6 | GO:0019003 | GDP binding(GO:0019003) |
| 0.6 | 2.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.6 | 34.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.6 | 5.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.6 | 7.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.6 | 5.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.6 | 28.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.6 | 9.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.6 | 2.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.6 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.6 | 1.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.6 | 20.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
| 0.6 | 2.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.6 | 6.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.6 | 13.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.6 | 11.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.6 | 6.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.6 | 4.9 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.6 | 2.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.6 | 14.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.6 | 153.1 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.6 | 3.0 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.6 | 1.8 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
| 0.6 | 5.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.6 | 3.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.6 | 4.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.6 | 2.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.6 | 6.3 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.6 | 3.4 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.6 | 2.9 | GO:0071253 | connexin binding(GO:0071253) |
| 0.6 | 41.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.6 | 4.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.6 | 2.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.5 | 13.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.5 | 3.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.5 | 7.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.5 | 2.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.5 | 2.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.5 | 129.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.5 | 91.4 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.5 | 2.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.5 | 5.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.5 | 0.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.5 | 2.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.5 | 2.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.5 | 2.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.5 | 1.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.5 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.5 | 33.6 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.5 | 2.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.5 | 1.6 | GO:0034618 | arginine binding(GO:0034618) |
| 0.5 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.5 | 54.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.5 | 1.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.5 | 1.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 0.5 | 1.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.5 | 4.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
| 0.5 | 1.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.5 | 2.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.5 | 13.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.5 | 11.4 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.5 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.5 | 1.4 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.5 | 9.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.5 | 7.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.5 | 8.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.5 | 0.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.5 | 1.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.5 | 4.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 4.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.5 | 0.5 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.5 | 2.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.5 | 0.9 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.5 | 2.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.4 | 2.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.4 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 2.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.4 | 1.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.4 | 4.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.4 | 2.6 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.4 | 1.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.4 | 2.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.4 | 1.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.4 | 7.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
| 0.4 | 6.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.4 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.4 | 6.5 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.4 | 4.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.4 | 18.9 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
| 0.4 | 3.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.4 | 7.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.4 | 4.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.4 | 7.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.4 | 5.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.4 | 3.8 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.4 | 2.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.4 | 4.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.4 | 1.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.4 | 4.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.4 | 1.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.4 | 2.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.4 | 2.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.4 | 2.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.4 | 3.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.3 | 18.7 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.3 | 5.5 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
| 0.3 | 1.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.3 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.3 | 4.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.3 | 4.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.3 | 2.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.3 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 3.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.3 | 6.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 53.4 | GO:0005543 | phospholipid binding(GO:0005543) |
| 0.3 | 0.9 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 0.9 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 0.3 | 10.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.3 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.3 | 1.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.3 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 1.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.3 | 3.8 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.3 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
| 0.3 | 1.4 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.3 | 1.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.3 | 23.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.3 | 3.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.3 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.3 | 3.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.3 | 0.6 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.3 | 1.9 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.3 | 47.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.3 | 0.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.3 | 1.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.3 | 1.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.3 | 2.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.3 | 1.3 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
| 0.3 | 1.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.3 | 1.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.3 | 0.8 | GO:0045127 | N-acylmannosamine kinase activity(GO:0009384) N-acetylglucosamine kinase activity(GO:0045127) |
| 0.3 | 3.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 1.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.3 | 6.9 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.3 | 0.3 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.2 | 1.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 1.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 1.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.2 | 1.7 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.2 | 3.4 | GO:0048038 | quinone binding(GO:0048038) |
| 0.2 | 7.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.2 | 1.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.2 | 47.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.2 | 1.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.2 | 1.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.2 | 4.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.2 | 3.0 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.2 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.2 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.2 | 2.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.2 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 5.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.2 | 0.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.2 | 1.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 13.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.2 | 10.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.2 | 0.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.2 | 3.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.2 | 2.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.8 | GO:0019863 | IgE binding(GO:0019863) |
| 0.2 | 11.9 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.2 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 0.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.2 | 2.5 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.2 | 0.6 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.2 | 1.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 18.7 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
| 0.2 | 2.7 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.2 | 1.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.2 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.2 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 8.7 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
| 0.2 | 17.1 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.2 | 0.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.2 | 0.5 | GO:0016248 | channel inhibitor activity(GO:0016248) |
| 0.2 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.2 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.2 | 0.5 | GO:0098809 | nitrite reductase activity(GO:0098809) |
| 0.2 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 0.5 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.2 | 3.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.2 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.2 | 2.3 | GO:0017022 | myosin binding(GO:0017022) |
| 0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.2 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.2 | 3.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 44.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.2 | 1.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 2.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 0.7 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.1 | 3.8 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
| 0.1 | 1.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 4.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 1.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.1 | 2.3 | GO:0003774 | motor activity(GO:0003774) |
| 0.1 | 0.4 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 2.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 2.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 1.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.1 | 1.1 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 1.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 1.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 1.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.1 | 0.3 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
| 0.1 | 0.2 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.1 | 0.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 0.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.2 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.1 | 2.0 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.6 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.1 | 3.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 0.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.1 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 1.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 1.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.1 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
| 0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.0 | 0.4 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 3.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.0 | 5.3 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.7 | 113.8 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 6.5 | 98.1 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
| 4.0 | 71.4 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 3.9 | 11.8 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 3.4 | 147.7 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 3.0 | 35.9 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
| 3.0 | 11.9 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 2.7 | 82.2 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 2.5 | 96.3 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 2.4 | 137.2 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 1.9 | 15.6 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 1.9 | 35.2 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 1.8 | 7.3 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 1.6 | 47.5 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 1.5 | 13.5 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 1.5 | 43.5 | PID_ARF_3PATHWAY | Arf1 pathway |
| 1.4 | 13.0 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 1.4 | 25.8 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 1.3 | 64.8 | PID_BMP_PATHWAY | BMP receptor signaling |
| 1.2 | 5.9 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 1.2 | 34.3 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 1.2 | 12.9 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 1.2 | 2.3 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 1.1 | 13.6 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 1.1 | 35.3 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 1.1 | 40.6 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 1.1 | 3.2 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 1.1 | 5.3 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 1.0 | 15.7 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.0 | 17.7 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 1.0 | 11.2 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
| 1.0 | 101.4 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 1.0 | 44.4 | PID_FGF_PATHWAY | FGF signaling pathway |
| 1.0 | 16.2 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 1.0 | 18.1 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.9 | 17.0 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.9 | 10.0 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
| 0.9 | 19.4 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.9 | 22.9 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.9 | 15.8 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.8 | 30.7 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
| 0.8 | 16.8 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.8 | 15.7 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.8 | 8.4 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.8 | 2.3 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.7 | 8.1 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.7 | 2.9 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.7 | 8.0 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.7 | 7.9 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.7 | 2.0 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.6 | 8.9 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.6 | 1.8 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.6 | 7.1 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.6 | 0.6 | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.6 | 5.0 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.6 | 0.6 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
| 0.5 | 8.6 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.5 | 10.3 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.5 | 7.7 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.5 | 32.8 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.5 | 2.4 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.5 | 1.8 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.4 | 0.9 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.4 | 5.5 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.4 | 4.9 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.4 | 1.6 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.4 | 5.8 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.4 | 3.1 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.4 | 21.5 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.4 | 0.4 | PID_AVB3_OPN_PATHWAY | Osteopontin-mediated events |
| 0.3 | 4.6 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
| 0.3 | 4.0 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.3 | 5.1 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.3 | 5.8 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.3 | 8.4 | PID_ATM_PATHWAY | ATM pathway |
| 0.3 | 14.1 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.3 | 11.3 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.2 | 26.5 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 3.3 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.2 | 7.6 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.2 | 1.0 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 1.0 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 2.2 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.2 | 2.8 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.2 | 9.4 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.2 | 1.1 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 0.4 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.1 | 0.6 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 1.3 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 1.2 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 0.3 | PID_ER_NONGENOMIC_PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 0.8 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 1.2 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.1 | 0.5 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 0.2 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 0.8 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 0.4 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 1.0 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.1 | 4.4 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.1 | 0.9 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.8 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 0.4 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.2 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 0.1 | NABA_CORE_MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 18.2 | 18.2 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 7.5 | 60.3 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
| 6.9 | 83.0 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 4.9 | 38.9 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 4.8 | 38.8 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 4.6 | 32.2 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 4.0 | 52.5 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 3.9 | 136.1 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 3.8 | 161.0 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 3.6 | 57.8 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 3.6 | 79.1 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 3.5 | 35.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 3.5 | 84.5 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 3.4 | 43.8 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 3.2 | 64.8 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 3.2 | 6.3 | REACTOME_SIGNALLING_BY_NGF | Genes involved in Signalling by NGF |
| 3.1 | 6.1 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 3.0 | 42.2 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 2.9 | 8.7 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 2.9 | 8.6 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 2.8 | 87.4 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 2.7 | 11.0 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 2.6 | 23.0 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 2.5 | 89.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 2.5 | 81.5 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 2.3 | 4.7 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 2.3 | 27.0 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 2.2 | 66.0 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 2.2 | 6.5 | REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 2.1 | 27.9 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 2.0 | 36.8 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.9 | 18.9 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 1.9 | 5.7 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 1.8 | 12.8 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 1.8 | 37.9 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 1.7 | 20.5 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 1.7 | 11.6 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 1.6 | 62.7 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 1.6 | 61.2 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 1.5 | 41.6 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 1.5 | 22.8 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 1.5 | 13.7 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 1.5 | 33.2 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 1.5 | 2.9 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 1.5 | 14.6 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 1.4 | 15.8 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.4 | 1.4 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 1.4 | 38.9 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
| 1.4 | 9.7 | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 1.4 | 16.4 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 1.4 | 35.5 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 1.4 | 9.5 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 1.4 | 8.1 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 1.3 | 44.8 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 1.3 | 31.3 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 1.3 | 32.1 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 1.3 | 19.1 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 1.3 | 23.8 | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | Genes involved in Post NMDA receptor activation events |
| 1.2 | 6.2 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.2 | 3.6 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.2 | 2.4 | REACTOME_G_PROTEIN_ACTIVATION | Genes involved in G-protein activation |
| 1.2 | 2.4 | REACTOME_SHC_MEDIATED_SIGNALLING | Genes involved in SHC-mediated signalling |
| 1.2 | 2.4 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
| 1.2 | 6.9 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
| 1.1 | 18.3 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 1.1 | 7.9 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 1.1 | 7.7 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 1.1 | 22.9 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 1.1 | 1.1 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
| 1.0 | 13.2 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 1.0 | 23.6 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 1.0 | 3.9 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.9 | 13.1 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.9 | 35.6 | REACTOME_ION_CHANNEL_TRANSPORT | Genes involved in Ion channel transport |
| 0.9 | 13.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.9 | 10.9 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.9 | 6.3 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.9 | 19.7 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.9 | 14.5 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.9 | 11.1 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.8 | 10.1 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.8 | 5.1 | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.8 | 10.0 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.8 | 12.1 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.8 | 99.8 | REACTOME_NEURONAL_SYSTEM | Genes involved in Neuronal System |
| 0.8 | 7.2 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.8 | 8.6 | REACTOME_INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.8 | 3.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.8 | 49.1 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.8 | 64.5 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.7 | 5.2 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.7 | 5.9 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.7 | 30.1 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.7 | 31.4 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.7 | 3.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.7 | 49.7 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.7 | 5.6 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.7 | 7.7 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.7 | 7.7 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.7 | 4.6 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.6 | 14.9 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.6 | 15.3 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.6 | 7.6 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.6 | 0.6 | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | Genes involved in Prolonged ERK activation events |
| 0.6 | 14.9 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.6 | 7.7 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.5 | 8.8 | REACTOME_INTEGRATION_OF_PROVIRUS | Genes involved in Integration of provirus |
| 0.5 | 6.2 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.5 | 6.7 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.5 | 13.2 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.5 | 15.9 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.5 | 4.4 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
| 0.5 | 22.6 | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | Genes involved in G alpha (s) signalling events |
| 0.5 | 6.2 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.5 | 9.4 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.5 | 11.4 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.4 | 1.3 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.4 | 7.5 | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.4 | 38.9 | REACTOME_DNA_REPAIR | Genes involved in DNA Repair |
| 0.4 | 13.5 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.4 | 11.3 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.4 | 3.7 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.4 | 4.9 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.4 | 39.7 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.4 | 10.9 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.4 | 13.9 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
| 0.4 | 0.4 | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.4 | 1.5 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.3 | 5.9 | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.3 | 6.6 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.3 | 2.6 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.3 | 4.1 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.3 | 2.4 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.3 | 2.8 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.3 | 1.6 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.3 | 2.0 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 7.2 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 1.7 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 12.3 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 0.2 | REACTOME_SIGNALING_BY_NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.2 | 18.6 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 1.6 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 0.2 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.2 | 2.6 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 2.7 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.2 | 4.5 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 0.4 | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.2 | 4.1 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 9.6 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.2 | 1.7 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 2.1 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 0.3 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 1.9 | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.1 | 2.5 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 4.0 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.0 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 0.5 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 1.4 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 3.0 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 6.6 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 6.8 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 0.5 | REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.1 | 1.1 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 0.7 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 0.2 | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 2.8 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 1.8 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.1 | 2.2 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 2.8 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.1 | 5.0 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 2.4 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 3.5 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 0.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 1.9 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 0.3 | REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 1.6 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.7 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.0 | 0.1 | REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.0 | 0.3 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.3 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
|
|
|